WO1993009176A3 - Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release - Google Patents
Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release Download PDFInfo
- Publication number
- WO1993009176A3 WO1993009176A3 PCT/US1992/009364 US9209364W WO9309176A3 WO 1993009176 A3 WO1993009176 A3 WO 1993009176A3 US 9209364 W US9209364 W US 9209364W WO 9309176 A3 WO9309176 A3 WO 9309176A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polymerizable
- materials
- polycations
- encapsulation
- alginate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
- C08F290/08—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated side groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
- C08F290/08—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated side groups
- C08F290/10—Polymers provided for in subclass C08B
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00157—Wound bandages for burns or skin transplants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00217—Wound bandages not adhering to the wound
- A61F2013/00229—Wound bandages not adhering to the wound with alginate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00544—Plasters form or structure
- A61F2013/00574—Plasters form or structure shaped as a body part
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00544—Plasters form or structure
- A61F2013/00621—Plasters form or structure cast
- A61F2013/00625—Plasters form or structure cast in situ
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00544—Plasters form or structure
- A61F2013/00621—Plasters form or structure cast
- A61F2013/00638—Gel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00655—Plasters adhesive
- A61F2013/00676—Plasters adhesive hydrogel
- A61F2013/0068—Plasters adhesive hydrogel cross-linked by radiations, e.g. electron beam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00727—Plasters means for wound humidity control
- A61F2013/00748—Plasters means for wound humidity control with hydrocolloids or superabsorbers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00855—Plasters pervious to air or vapours
- A61F2013/00876—Plasters pervious to air or vapours vapour permeability >500 g/mg/24h
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/00906—Plasters containing means for transcutaneous or transdermal drugs application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/0091—Plasters containing means with disinfecting or anaesthetics means, e.g. anti-mycrobic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5508638A JPH07503943A (en) | 1991-10-29 | 1992-10-29 | Cross-linked polysaccharides, polycations and lipids useful for encapsulation and drug release |
EP92925046A EP0610441A4 (en) | 1991-10-29 | 1992-10-29 | Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release. |
US08/232,054 US5837747A (en) | 1991-10-29 | 1992-10-29 | Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78426791A | 1991-10-29 | 1991-10-29 | |
US784,267 | 1991-10-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1993009176A2 WO1993009176A2 (en) | 1993-05-13 |
WO1993009176A3 true WO1993009176A3 (en) | 1993-07-22 |
Family
ID=25131895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1992/009364 WO1993009176A2 (en) | 1991-10-29 | 1992-10-29 | Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release |
Country Status (6)
Country | Link |
---|---|
US (4) | US5837747A (en) |
EP (1) | EP0610441A4 (en) |
JP (1) | JPH07503943A (en) |
AU (1) | AU3124793A (en) |
CA (1) | CA2121129A1 (en) |
WO (1) | WO1993009176A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8834451B2 (en) | 2002-10-28 | 2014-09-16 | Smith & Nephew Plc | In-situ wound cleansing apparatus |
US8858964B2 (en) | 2010-04-15 | 2014-10-14 | Marine Polymer Technologies, Inc. | Anti-bacterial applications of poly-N-acetylglucosamine nanofibers |
US8998866B2 (en) | 2010-07-02 | 2015-04-07 | Smith & Nephew Plc | Provision of wound filler |
US9139664B2 (en) | 2007-02-19 | 2015-09-22 | Marine Polymer Technologies, Inc. | Hemostatic compositions and therapeutic regimens |
Families Citing this family (230)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5380536A (en) * | 1990-10-15 | 1995-01-10 | The Board Of Regents, The University Of Texas System | Biocompatible microcapsules |
US5529914A (en) | 1990-10-15 | 1996-06-25 | The Board Of Regents The Univeristy Of Texas System | Gels for encapsulation of biological materials |
US20040195710A1 (en) * | 1990-10-15 | 2004-10-07 | Hubbell Jeffrey A. | Gels for encapsulation of biological materials |
US5462990A (en) * | 1990-10-15 | 1995-10-31 | Board Of Regents, The University Of Texas System | Multifunctional organic polymers |
US5573934A (en) | 1992-04-20 | 1996-11-12 | Board Of Regents, The University Of Texas System | Gels for encapsulation of biological materials |
US20040138329A1 (en) * | 1992-04-20 | 2004-07-15 | Board Of Regents Of The University Of Texas System | Gels for encapsulation of biological materials |
EP0762874A4 (en) * | 1992-12-30 | 1997-08-06 | Clover Cons Ltd | Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials |
FR2702160B1 (en) * | 1993-03-02 | 1995-06-02 | Biovecteurs As | Synthetic particulate vectors and method of preparation. |
US6090925A (en) | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US5981719A (en) | 1993-03-09 | 1999-11-09 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US6203759B1 (en) | 1996-05-31 | 2001-03-20 | Packard Instrument Company | Microvolume liquid handling system |
US6521187B1 (en) | 1996-05-31 | 2003-02-18 | Packard Instrument Company | Dispensing liquid drops onto porous brittle substrates |
US6537817B1 (en) | 1993-05-31 | 2003-03-25 | Packard Instrument Company | Piezoelectric-drop-on-demand technology |
US6063911A (en) * | 1993-12-01 | 2000-05-16 | Marine Polymer Technologies, Inc. | Methods and compositions for treatment of cell proliferative disorders |
US5858350A (en) | 1993-12-01 | 1999-01-12 | Marine Polymer Technologies | Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy system |
US5532287A (en) * | 1994-05-04 | 1996-07-02 | Ciba-Geigy Corporation | Radiation cured drug release controlling membrane |
US5502042A (en) | 1994-07-22 | 1996-03-26 | United States Surgical Corporation | Methods and compositions for treating wounds |
JP3308742B2 (en) * | 1994-11-17 | 2002-07-29 | 生化学工業株式会社 | Photocrosslinkable hyaluronic acid derivative, crosslinked product thereof and methods for producing them |
IT1281886B1 (en) * | 1995-05-22 | 1998-03-03 | Fidia Advanced Biopolymers Srl | PROCESS FOR THE PREPARATION OF HYDROGELS OBTAINED FROM CHEMICAL DERIVATIVES OF HYALURONIC ACID BY MEANS OF ULTRAVIOLET IRRADIATION AND THEIR |
US6214331B1 (en) * | 1995-06-06 | 2001-04-10 | C. R. Bard, Inc. | Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained |
US6565842B1 (en) * | 1995-06-07 | 2003-05-20 | American Bioscience, Inc. | Crosslinkable polypeptide compositions |
US5827707A (en) * | 1995-06-07 | 1998-10-27 | Neocrin Company | Method for manufacturing minimal volume capsules containing biological materials |
US5968393A (en) * | 1995-09-12 | 1999-10-19 | Demaline; John Tracey | Hot water controller |
US5855613A (en) | 1995-10-13 | 1999-01-05 | Islet Sheet Medical, Inc. | Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change |
EP0861270B1 (en) * | 1995-11-15 | 2002-07-24 | Seikagaku Corporation | Photocured hyaluronic acid gel and method of preparation thereof |
US6458889B1 (en) | 1995-12-18 | 2002-10-01 | Cohesion Technologies, Inc. | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
US6833408B2 (en) | 1995-12-18 | 2004-12-21 | Cohesion Technologies, Inc. | Methods for tissue repair using adhesive materials |
US7883693B2 (en) | 1995-12-18 | 2011-02-08 | Angiodevice International Gmbh | Compositions and systems for forming crosslinked biomaterials and methods of preparation of use |
PT1704878E (en) | 1995-12-18 | 2013-07-17 | Angiodevice Internat Gmbh | Crosslinked polymer compositions and methods for their use |
AU1855297A (en) * | 1996-03-26 | 1997-10-17 | Vivorx Pharmaceuticals, Inc. | Storage articles for prolonged viability and function of living cells |
SE9601368D0 (en) * | 1996-04-11 | 1996-04-11 | Pharmacia Biotech Ab | Process for the production of a porous cross-linked polysaccharide gel |
DE69721265T2 (en) | 1996-07-01 | 2004-05-06 | Universiteit Utrecht | HYDROLYZABLE HYDROGELS FOR CONTROLLED RELEASE |
US6060534A (en) * | 1996-07-11 | 2000-05-09 | Scimed Life Systems, Inc. | Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties |
US6368356B1 (en) | 1996-07-11 | 2002-04-09 | Scimed Life Systems, Inc. | Medical devices comprising hydrogel polymers having improved mechanical properties |
US20040023375A1 (en) * | 2002-07-30 | 2004-02-05 | Precision Therapeutics, Inc. | Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays |
US5728541A (en) | 1996-07-12 | 1998-03-17 | Precision Therapeutics, Inc. | Method for preparing cell cultures from biologial specimens for chemotherapeutic and other assays |
US20040072722A1 (en) | 2002-10-10 | 2004-04-15 | Kornblith Paul L. | Methods for assessing efficacy of chemotherapeutic agents |
EP0927196B1 (en) * | 1996-09-19 | 2008-11-05 | The Regents Of The University Of Michigan | Polymers containing polysaccharides such as alginates or modified alginates |
EP1806367A3 (en) * | 1996-09-19 | 2007-11-28 | The Regents Of The University Of Michigan | Polymers containing polysaccharides such as alginates or modified alginates |
FR2755976B1 (en) * | 1996-11-15 | 1999-01-15 | Idm Immuno Designed Molecules | NOVEL COMPLEXES OF NUCLEIC ACIDS AND POLYMER SUBSTITUTED BY RESIDUES CAUSING THE DESTABILIZATION OF CELL MEMBRANES |
FR2755856B1 (en) * | 1996-11-21 | 1999-01-29 | Merck Clevenot Laboratoires | MICROCAPSULES OF CHINA OR CHINA DERIVATIVES CONTAINING A HYDROPHOBIC SUBSTANCE, IN PARTICULAR A SUN FILTER AND PROCESS FOR PREPARING SUCH MICROCAPSULES |
KR100430625B1 (en) * | 1997-01-30 | 2004-06-16 | 주식회사 코오롱 | Fiber product having excellent antibacterial properties and production thereof |
US7105724B2 (en) | 1997-04-04 | 2006-09-12 | Board Of Regents Of University Of Nebraska | Methods and materials for making and using transgenic dicamba-degrading organisms |
US6224893B1 (en) | 1997-04-11 | 2001-05-01 | Massachusetts Institute Of Technology | Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering |
US6656508B2 (en) * | 1997-04-17 | 2003-12-02 | Amgen Inc. | Sustained-release alginate gels |
GB9710049D0 (en) * | 1997-05-19 | 1997-07-09 | Nycomed Imaging As | Method |
US5861149A (en) * | 1997-06-04 | 1999-01-19 | Polyheal Ltd. | Methods for wound treatment |
ES2184294T3 (en) * | 1997-06-26 | 2003-04-01 | Smith & Nephew | PRODUCTS BASED ON CELL CULTURES. |
US6146771A (en) | 1997-07-01 | 2000-11-14 | Terumo Cardiovascular Systems Corporation | Process for modifying surfaces using the reaction product of a water-insoluble polymer and a polyalkylene imine |
US7923250B2 (en) | 1997-07-30 | 2011-04-12 | Warsaw Orthopedic, Inc. | Methods of expressing LIM mineralization protein in non-osseous cells |
EP1007673B1 (en) | 1997-07-30 | 2008-12-17 | Emory University | Novel bone mineralization proteins, dna, vectors, expression systems |
US6121027A (en) * | 1997-08-15 | 2000-09-19 | Surmodics, Inc. | Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups |
US6506895B2 (en) | 1997-08-15 | 2003-01-14 | Surmodics, Inc. | Photoactivatable nucleic acids |
US6958148B1 (en) * | 1998-01-20 | 2005-10-25 | Pericor Science, Inc. | Linkage of agents to body tissue using microparticles and transglutaminase |
US6410044B1 (en) | 1998-03-19 | 2002-06-25 | Surmodics, Inc. | Crosslinkable macromers |
US7547445B2 (en) * | 1998-03-19 | 2009-06-16 | Surmodics, Inc. | Crosslinkable macromers |
US6007833A (en) * | 1998-03-19 | 1999-12-28 | Surmodics, Inc. | Crosslinkable macromers bearing initiator groups |
US7060469B2 (en) * | 1998-04-02 | 2006-06-13 | The Board Of Regents Of The University Of Oklahoma | Polymer grafting by polysaccharide synthases |
DE19818077A1 (en) * | 1998-04-22 | 1999-10-28 | Biotechnolog Forschung Gmbh | Fixing substrate molecules in gel matrixes |
AU2003200609B2 (en) * | 1998-05-18 | 2006-02-23 | Amgen Inc. | Biodegradable sustained-release alginate gels |
US6432449B1 (en) * | 1998-05-18 | 2002-08-13 | Amgen Inc. | Biodegradable sustained-release alginate gels |
US6368866B1 (en) | 1998-08-03 | 2002-04-09 | Reference Diagnostics, Inc. | Rapid separation assay for total iron binding capacity |
US6238677B1 (en) * | 1998-08-18 | 2001-05-29 | The United States Of America As Represented By The Secretary Of Agriculture | Starch microcapsules for delivery of active agents |
US6350527B1 (en) * | 1998-08-27 | 2002-02-26 | Eidgenossische Technische Hochschule Zurich | Gels and multilayer surface structures from boronic acid containing polymers |
DE69925757T2 (en) * | 1998-08-31 | 2006-03-23 | Cornell Research Foundation, Inc. | DEXTRAN MALEIC ACID MONOESTER AND HYDROGELES THEREOF |
CA2351593C (en) * | 1998-11-11 | 2012-02-21 | The Board Of Regents Of The University Of Oklahoma | Polymer grafting by polysaccharide synthases |
US20060105431A1 (en) * | 1998-11-11 | 2006-05-18 | Deangelis Paul L | Polymer grafting by polysaccharide synthases using artificial sugar acceptors |
US7375096B1 (en) * | 1998-12-04 | 2008-05-20 | California Institute Of Technology | Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network |
SE523817C2 (en) * | 1999-02-05 | 2004-05-18 | Corline Systems Ab | Use of a coagulation prevention agent in conjunction with transplantation of insulin-producing cells |
US6410519B1 (en) | 1999-03-04 | 2002-06-25 | United States Surgical Corporation | Scar reduction |
US6495161B1 (en) | 1999-03-09 | 2002-12-17 | Vivorx, Inc. | Cytoprotective biocompatible containment systems for biologically active materials and methods of making same |
US6365385B1 (en) | 1999-03-22 | 2002-04-02 | Duke University | Methods of culturing and encapsulating pancreatic islet cells |
US6303355B1 (en) | 1999-03-22 | 2001-10-16 | Duke University | Method of culturing, cryopreserving and encapsulating pancreatic islet cells |
US7642071B2 (en) | 1999-04-01 | 2010-01-05 | The Board Of Regents Of The University Of Oklahoma | Methods of expressing gram-negative glycosaminoglycan synthase genes in gram-positive hosts |
WO2000060956A1 (en) * | 1999-04-12 | 2000-10-19 | Cornell Research Foundation, Inc. | Hydrogel-forming system with hydrophobic and hydrophilic components |
US6716445B2 (en) * | 1999-04-12 | 2004-04-06 | Cornell Research Foundation, Inc. | Hydrogel entrapping therapeutic agent and stent with coating comprising this |
US6852334B1 (en) * | 1999-04-20 | 2005-02-08 | The University Of British Columbia | Cationic peg-lipids and methods of use |
US6514535B2 (en) * | 1999-05-21 | 2003-02-04 | Noveon Ip Holdings Corp. | Bioadhesive hydrogels with functionalized degradable crosslinks |
EP1064913B1 (en) | 1999-07-02 | 2005-09-14 | Cognis IP Management GmbH | Microcaspules |
ATE258777T1 (en) * | 1999-07-02 | 2004-02-15 | Cognis Iberia Sl | MICRO CAPSULES - II |
US8188043B2 (en) * | 1999-07-28 | 2012-05-29 | The Board Of Trustees Of The Leland Stanford Jr. University | Nicotine in therapeutic angiogenesis and vasculogenesis |
JP2001037472A (en) * | 1999-07-28 | 2001-02-13 | Bio Quest:Kk | Three dimensional cell-culturing base medium and cell culture using the same |
JP2003508127A (en) * | 1999-08-27 | 2003-03-04 | デパートメント オブ ナショナル ディフェンス | Hydrogel wound dressing containing liposome-encapsulated therapeutic agent |
US6369037B1 (en) | 1999-10-19 | 2002-04-09 | Cornell Research Foundation, Inc. | Controlled release of doxorubicin |
US7534589B2 (en) * | 1999-11-10 | 2009-05-19 | The Board Of Regents Of The University Of Oklahoma | Polymer grafting by polysaccharide synthases |
US6753179B2 (en) * | 1999-12-08 | 2004-06-22 | Allmighty Co., Ltd. | Method for purification treatment of environmental pollutants |
US7070807B2 (en) * | 1999-12-29 | 2006-07-04 | Mixson A James | Branched histidine copolymers and methods for using same |
US8642051B2 (en) * | 2000-03-21 | 2014-02-04 | Suzanne Jaffe Stillman | Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s) |
US7189705B2 (en) * | 2000-04-20 | 2007-03-13 | The University Of British Columbia | Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers |
US6596310B1 (en) | 2000-08-23 | 2003-07-22 | Board Of Trustees Operating Michigan State University | Method of artificial insemination by timed release of sperm from capsules or solid beads |
US7625580B1 (en) * | 2000-11-28 | 2009-12-01 | Massachusetts Institute Of Technology | Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering |
JP4430254B2 (en) * | 2001-01-31 | 2010-03-10 | 関西ペイント株式会社 | Method for producing granular molded article for microbial cell immobilization |
US6913765B2 (en) | 2001-03-21 | 2005-07-05 | Scimed Life Systems, Inc. | Controlling resorption of bioresorbable medical implant material |
KR100457546B1 (en) * | 2001-05-02 | 2004-11-18 | 주식회사 바이오프로젠 | A microsphere and process for producting thereof using polyfructose and its derivatives |
US8101196B2 (en) * | 2001-06-26 | 2012-01-24 | Biointeractions, Ltd. | Polysaccharide biomaterials and methods of use thereof |
MY169670A (en) * | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
EP1306128A1 (en) * | 2001-10-29 | 2003-05-02 | Tenaxis Gmbh | Sorptive composite materials |
DE10157046A1 (en) * | 2001-11-18 | 2003-06-12 | Novosom Ag | Nano and microcapsules comprising reactive polymers |
US6809231B2 (en) * | 2001-11-21 | 2004-10-26 | The United States Of America As Represented By The Secretary Of Agriculture | Flexible and absorbent alginate wound dressing |
US20040266026A1 (en) * | 2002-01-10 | 2004-12-30 | Amiji Mansoor M. | Hybrid immobilized catalytic system with controlled permeability |
US20050260259A1 (en) * | 2004-04-23 | 2005-11-24 | Bolotin Elijah M | Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
US7635463B2 (en) * | 2002-02-27 | 2009-12-22 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials |
DE60335608D1 (en) * | 2002-02-27 | 2011-02-17 | Pharmain Corp | COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS AND OTHER MATERIALS AND METHOD FOR THE PRODUCTION AND USE THEREOF |
US20040009210A1 (en) * | 2002-07-09 | 2004-01-15 | Kimberly-Clark Worldwide, Inc. | Wound management products incorporating cationic compounds |
US20040009141A1 (en) * | 2002-07-09 | 2004-01-15 | Kimberly-Clark Worldwide, Inc. | Skin cleansing products incorporating cationic compounds |
US7846141B2 (en) | 2002-09-03 | 2010-12-07 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
BRPI0314042B8 (en) | 2002-09-06 | 2021-05-25 | Calando Pharmaceuticals Inc | cyclodextrin-based polymers for the delivery of covalently linked therapeutic agents |
US7862831B2 (en) * | 2002-10-09 | 2011-01-04 | Synthasome, Inc. | Method and material for enhanced tissue-biomaterial integration |
US8673333B2 (en) * | 2002-09-25 | 2014-03-18 | The Johns Hopkins University | Cross-linked polymer matrices, and methods of making and using same |
US20050069572A1 (en) * | 2002-10-09 | 2005-03-31 | Jennifer Elisseeff | Multi-layered polymerizing hydrogels for tissue regeneration |
BR0315130A (en) | 2002-10-11 | 2005-08-16 | Novocell Inc | Therapeutically effective cell therapy and biological material encapsulation compositions, their method and use |
ATE457716T1 (en) | 2002-12-30 | 2010-03-15 | Angiotech Int Ag | RELEASE OF ACTIVE INGREDIENTS FROM QUICK-GELLING POLYMER COMPOSITION |
US7008476B2 (en) * | 2003-06-11 | 2006-03-07 | Az Electronic Materials Usa Corp. | Modified alginic acid of alginic acid derivatives and thermosetting anti-reflective compositions thereof |
US20050208095A1 (en) * | 2003-11-20 | 2005-09-22 | Angiotech International Ag | Polymer compositions and methods for their use |
FR2862980B1 (en) * | 2003-11-28 | 2006-03-03 | Biopredic Internat | MEANS FOR TRANSPORTING AND PRESERVING LIVING CELLS OR FABRICS |
GB2408741B (en) | 2003-12-04 | 2008-06-18 | Ind Tech Res Inst | Hyaluronic acid derivative with urethane linkage |
US8313765B2 (en) * | 2003-12-04 | 2012-11-20 | Industrial Technology Research Institute | Biodegradable hyaluronic acid derivative, biodegradable polymeric micelle composition and pharmaceutical or bioactive composition |
US8062272B2 (en) | 2004-05-21 | 2011-11-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US10058642B2 (en) | 2004-04-05 | 2018-08-28 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
GB0409446D0 (en) | 2004-04-28 | 2004-06-02 | Smith & Nephew | Apparatus |
KR101148445B1 (en) | 2004-04-28 | 2012-07-05 | 안지오디바이스 인터내셔널 게엠베하 | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
JP5026956B2 (en) * | 2004-05-12 | 2012-09-19 | サーモディクス,インコーポレイティド | Natural biodegradable polysaccharide coating for medical devices |
EP1595534A1 (en) * | 2004-05-13 | 2005-11-16 | Universiteit Utrecht Holding B.V. | Gel composition comprising charged polymers |
DK1796747T3 (en) * | 2004-08-27 | 2017-10-16 | Antonio Lauto | BIOADHASIVE MOVIE FOR TISSUE REPAIR |
CA2581093C (en) | 2004-09-17 | 2014-11-18 | Angiotech Biomaterials Corporation | Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
EP1811933B1 (en) | 2004-09-28 | 2016-03-23 | Atrium Medical Corporation | Barrier layer |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
WO2006089119A2 (en) * | 2005-02-18 | 2006-08-24 | Cartilix, Inc. | Biological adhesive |
US9119901B2 (en) * | 2005-04-28 | 2015-09-01 | Warsaw Orthopedic, Inc. | Surface treatments for promoting selective tissue attachment to medical impants |
US8414907B2 (en) | 2005-04-28 | 2013-04-09 | Warsaw Orthopedic, Inc. | Coatings on medical implants to guide soft tissue healing |
CA2620936A1 (en) * | 2005-09-01 | 2007-03-08 | Precision Therapeutics, Inc. | Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics |
WO2007040557A1 (en) | 2005-09-21 | 2007-04-12 | Surmodics, Inc. | Coatings and articles including natural biodegradable polysaccharides |
JP5226517B2 (en) * | 2005-09-21 | 2013-07-03 | サーモディクス,インコーポレイティド | In vivo formed matrices containing natural biodegradable polysaccharides and their ocular use |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US9427423B2 (en) * | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
GB2432790A (en) * | 2005-12-01 | 2007-06-06 | David William Richardson | A wound dressing with active ingredients |
KR101872061B1 (en) | 2005-12-19 | 2018-06-27 | 파마인 코포레이션 | Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
CN101405303B (en) * | 2006-03-14 | 2011-11-23 | 诺维信生物制药丹麦公司 | Acrylated hyaluronic acid |
US20070280986A1 (en) * | 2006-06-01 | 2007-12-06 | Carlos Gil | Intra-operative coating of implants |
WO2007146319A2 (en) * | 2006-06-13 | 2007-12-21 | Symphony Medical, Inc. | Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications |
US20100038311A1 (en) * | 2006-07-06 | 2010-02-18 | Hitachi Plant Technologies, Ltd. | Entrapping immobilization pellets, wastewater treatment system using the entrapping immobilization pellets and wastewater treatment method |
US20080089923A1 (en) * | 2006-09-29 | 2008-04-17 | Burkstrand Michael J | Biodegradable ocular implants and methods for treating ocular conditions |
US20080248108A1 (en) * | 2006-10-06 | 2008-10-09 | Jain Krotz | Multilayered polyelectrolyte-based capsules for cell encapsulation and delivery of therapeutic compositions |
KR100852889B1 (en) | 2006-11-07 | 2008-08-19 | 이석근 | Algin-Cellulose Hybrid and method of the same that |
WO2008073295A2 (en) * | 2006-12-07 | 2008-06-19 | Surmodics, Inc. | Latent stabilization of bioactive agents releasable from implantable medical articles |
US20080176958A1 (en) | 2007-01-24 | 2008-07-24 | Insert Therapeutics, Inc. | Cyclodextrin-based polymers for therapeutics delivery |
TWI494133B (en) * | 2007-03-14 | 2015-08-01 | Tibotec Pharm Ltd | Powders for reconstitution |
US7960336B2 (en) | 2007-08-03 | 2011-06-14 | Pharmain Corporation | Composition for long-acting peptide analogs |
US8563527B2 (en) | 2007-08-20 | 2013-10-22 | Pharmain Corporation | Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same |
KR20100049084A (en) | 2007-08-23 | 2010-05-11 | 인트렉손 코포레이션 | Methods and compositions for diagnosing disease |
US20110136935A1 (en) * | 2007-08-30 | 2011-06-09 | National University Of Singapore | Bone and/or dental cement composition and uses thereof |
EP2185637B1 (en) | 2007-09-19 | 2013-04-03 | SurModics, Inc. | Biocompatible foams, systems, and methods |
NZ584848A (en) | 2007-09-28 | 2012-09-28 | Intrexon Corp | Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof |
CN101172168B (en) * | 2007-10-10 | 2010-06-02 | 大连理工大学 | Metallic blood vessel bracket coating for osamine glycan load CD133 antibody and method for preparing the same |
EP2217298B1 (en) | 2007-11-21 | 2015-11-11 | T.J. Smith & Nephew Limited | Suction device and dressing |
DK3000448T3 (en) | 2007-11-21 | 2019-01-21 | Smith & Nephew | Wound dressing |
GB0722820D0 (en) | 2007-11-21 | 2008-01-02 | Smith & Nephew | Vacuum assisted wound dressing |
GB0723875D0 (en) | 2007-12-06 | 2008-01-16 | Smith & Nephew | Wound management |
US11253399B2 (en) | 2007-12-06 | 2022-02-22 | Smith & Nephew Plc | Wound filling apparatuses and methods |
US20090176892A1 (en) * | 2008-01-09 | 2009-07-09 | Pharmain Corporation | Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same |
US20090196854A1 (en) * | 2008-02-04 | 2009-08-06 | Kytos Biosystems S.A. | Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery |
US20090202642A1 (en) * | 2008-02-08 | 2009-08-13 | Xiao Huang | Drug Delivery System Comprising Microparticles and Gelation System |
GB0803564D0 (en) | 2008-02-27 | 2008-04-02 | Smith & Nephew | Fluid collection |
US20090238815A1 (en) * | 2008-03-18 | 2009-09-24 | Medtronic Vascular, Inc. | Nondegradable Hydrogels For Medical Device Application |
EP2271416A4 (en) * | 2008-04-25 | 2012-07-04 | Biocius Life Sciences Inc | Separation cartridges and methods for fabrication and use thereof |
WO2009137689A2 (en) * | 2008-05-07 | 2009-11-12 | Surmodics, Inc. | Delivery of nucleic acid complexes from particles |
US9694055B2 (en) | 2008-05-09 | 2017-07-04 | Wake Forest University Health Sciences | Renal tissue regeneration |
US20090294049A1 (en) * | 2008-06-02 | 2009-12-03 | Medtronic Vascular, Inc. | Biodegradable Adhesive Hydrogels |
US20110182957A1 (en) * | 2008-06-19 | 2011-07-28 | Nicoll Steven B | Cellulosics for tissue replacement |
US9392788B2 (en) * | 2008-11-07 | 2016-07-19 | North Carolina State University | Mosquito attractant compositions and methods |
US9193948B2 (en) | 2008-11-12 | 2015-11-24 | The Trustees Of The University Of Pennsylvania | Biomaterials for tissue replacement |
US9198872B2 (en) | 2008-12-08 | 2015-12-01 | University Of Miami | Dendritic and hyperbranched polymers for cellular encapsulation and functionalization |
US8728520B2 (en) * | 2008-12-08 | 2014-05-20 | University Of Miami | Cross-linked alginate-polyalkylene glycol polymer coatings for encapsulation and methods of making the same |
WO2010083039A1 (en) * | 2009-01-14 | 2010-07-22 | Cornell University | Preparing biodgradable hydrogel for biomedical application |
US9259507B2 (en) * | 2009-04-21 | 2016-02-16 | Warsaw Orthopedic, Inc. | Tissue augmentation with active agent for wound healing |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
US9006182B2 (en) * | 2009-11-10 | 2015-04-14 | Conversion Energy Enterprises, Inc. | Light activated composite tissue adhesives |
CA2781669A1 (en) * | 2009-11-23 | 2011-05-26 | Cerulean Pharma Inc. | Cyclodextrin-based polymers for therapeutic delivery |
US8784858B2 (en) | 2009-12-21 | 2014-07-22 | Janssen R&D Ireland | Degradable removable implant for the sustained release of an active compound |
US8790621B2 (en) * | 2010-04-12 | 2014-07-29 | Iowa State University Research Foundation, Inc. | Nanoparticles and nanoparticle compositions |
US9061095B2 (en) | 2010-04-27 | 2015-06-23 | Smith & Nephew Plc | Wound dressing and method of use |
EP2593141B1 (en) | 2010-07-16 | 2018-07-04 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
DE102010040687A1 (en) * | 2010-09-14 | 2012-03-15 | Hamilton Bonaduz Ag | Process for producing active agent beads |
US9012406B2 (en) | 2010-11-10 | 2015-04-21 | Conversion Energy Enterprises, Inc. | Light activated composite tissue adhesives |
FR2967677B1 (en) * | 2010-11-18 | 2014-05-16 | Centre Nat Rech Scient | POLYSACCHARIDE DERIVATIVES COMPRISING ALKENOUS PATTERN AND THIO-CLICK CHEMICAL COUPLING REACTION |
GB201020005D0 (en) | 2010-11-25 | 2011-01-12 | Smith & Nephew | Composition 1-1 |
EP2643412B1 (en) | 2010-11-25 | 2016-08-17 | Smith & Nephew PLC | Composition i-ii and products and uses thereof |
US8901092B2 (en) | 2010-12-29 | 2014-12-02 | Surmodics, Inc. | Functionalized polysaccharides for active agent delivery |
EP2680862B1 (en) | 2011-03-04 | 2016-07-20 | Wake Forest University Health Sciences | Encapsulated cells for hormone replacement therapy |
FI20115279A0 (en) * | 2011-03-22 | 2011-03-22 | Teknologian Tutkimuskeskus Vtt Oy | A method of making a hydrogel from a xylan polysaccharide and a hydrogel |
CN107412256A (en) | 2011-04-15 | 2017-12-01 | 海洋聚合物技术公司 | Disease is treated with poly- N acetyl glucosamines nanofiber |
US9567357B2 (en) | 2011-06-24 | 2017-02-14 | Biointeractions Ltd. | Biocompatible, biomimetic ampholyte materials |
US20150159066A1 (en) | 2011-11-25 | 2015-06-11 | Smith & Nephew Plc | Composition, apparatus, kit and method and uses thereof |
US10226536B2 (en) * | 2011-11-28 | 2019-03-12 | Case Western Reserve University | Polysaccharide therapeutic conjugates |
US10470478B2 (en) * | 2012-04-12 | 2019-11-12 | Cure Pharmaceutical Corporation | Protein-polysaccharide macromolecular complex article of manufacture containing encapsulated ethyl alcohol |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
WO2014055493A1 (en) | 2012-10-02 | 2014-04-10 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
US20160120706A1 (en) | 2013-03-15 | 2016-05-05 | Smith & Nephew Plc | Wound dressing sealant and use thereof |
US10918765B2 (en) | 2013-04-11 | 2021-02-16 | University Of Vermont And State Agricultural College | Decellularization and recellularization of whole organs |
USRE49528E1 (en) | 2013-04-26 | 2023-05-16 | Biointeractions Ltd. | Bioactive coatings |
CA2910000C (en) | 2013-04-26 | 2023-01-03 | Biointeractions Limited | Bioactive coating comprising a polymer having both guandine and heparin covalently bonded thereto as pendant groups |
UA120037C2 (en) | 2013-05-15 | 2019-09-25 | Зе Боард Оф Трастеес Оф Зе Леланд Станфорд Джуніор Юніверсіті | Modulation of heparin-binding epidermal growth factor activity for tympanic membrane healing |
US10471118B2 (en) | 2014-05-30 | 2019-11-12 | Case Western Reserve University | Retinylamine derivitives for treatment of ocular disorders |
US11129845B2 (en) | 2014-06-18 | 2021-09-28 | Case Western Reserve University | Compositions and methods for the delivery of nucleic acids |
US10925980B2 (en) | 2014-08-04 | 2021-02-23 | Case Western Reserve University | Molecular probes and methods of use |
US11407786B2 (en) | 2015-06-18 | 2022-08-09 | Case Western Reserve University | Compositions and methods for the delivery of nucleic acids |
US9730867B2 (en) | 2016-01-06 | 2017-08-15 | The Procter & Gamble Company | Methods of forming a slurry with microcapsules formed from phosphate esters |
US9732303B2 (en) | 2016-01-06 | 2017-08-15 | The Procter & Gamble Company | Microcapsules formed from phosphate esters and compositions containing same |
US10154947B2 (en) | 2016-01-06 | 2018-12-18 | The Procter & Gamble Company | Antiperspirant composition |
US11655343B2 (en) * | 2016-03-24 | 2023-05-23 | Takeda Pharmaceutical Company Limited | Alginate hydrogel compositions |
US20190076535A1 (en) * | 2017-02-20 | 2019-03-14 | Joshua Alan Held | Crosslinked protein-polysaccharide complexed consumable macrocapsule |
CN110891611B (en) | 2017-03-22 | 2024-03-29 | 阿森迪斯制药公司 | Hydrogel crosslinked hyaluronic acid prodrug compositions and methods |
US11794161B1 (en) | 2018-11-21 | 2023-10-24 | Trucapsol, Llc | Reduced permeability microcapsules |
EP3908246A4 (en) | 2019-01-11 | 2022-11-16 | Encapsys, LLC | Incorporation of chitosan in microcapsule wall |
US11571674B1 (en) | 2019-03-28 | 2023-02-07 | Trucapsol Llc | Environmentally biodegradable microcapsules |
US11542392B1 (en) | 2019-04-18 | 2023-01-03 | Trucapsol Llc | Multifunctional particle additive for enhancement of toughness and degradation in biodegradable polymers |
CN111825863B (en) * | 2019-04-18 | 2021-09-28 | 四川大学 | Disulfide bond crosslinked gelatin/epsilon-polylysine active food packaging film and preparation method thereof |
US20230002566A1 (en) | 2019-12-05 | 2023-01-05 | B.G. Negev Technologies and Application Ltd., at Ben-Gurion University | Biodegradable polymeric compositions, methods of preparation and uses thereof |
US11465117B2 (en) | 2020-01-30 | 2022-10-11 | Trucapsol Llc | Environmentally biodegradable microcapsules |
WO2022061054A1 (en) * | 2020-09-18 | 2022-03-24 | Encapsys, Llc | Multifunctional (meth)acrylate polysaccharide microcapsules |
KR20230157994A (en) * | 2021-03-02 | 2023-11-17 | 셀크래프트 엘티디. | Method for producing crosslinkable biopolymers |
CN113398901B (en) * | 2021-05-28 | 2022-11-08 | 广西大学 | Biomass-based thermosensitive bionic hydrogel adsorption material and preparation method and application thereof |
CN113499473B (en) * | 2021-06-21 | 2022-05-10 | 四川大学 | Multifunctional antibacterial dressing, preparation method and application |
CN114471707B (en) * | 2021-12-23 | 2023-06-16 | 中国石油大学(华东) | Hydrogel sphere containing catalyst, preparation method thereof and application thereof in photocatalytic treatment of organic pollutants |
US11878280B2 (en) | 2022-04-19 | 2024-01-23 | Trucapsol Llc | Microcapsules comprising natural materials |
CN114796597B (en) * | 2022-04-24 | 2023-08-04 | 福建师范大学 | Sphingosine-based hydrogel and preparation method and application thereof |
WO2024006528A1 (en) * | 2022-07-01 | 2024-01-04 | Sigilon Therapeutics, Inc. | Covalently photocrosslinked polysaccharides and methods of use thereof |
US11904288B1 (en) | 2023-02-13 | 2024-02-20 | Trucapsol Llc | Environmentally biodegradable microcapsules |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3332897A (en) * | 1964-12-21 | 1967-07-25 | Nat Starch Chem Corp | Process of grafting monomers onto polysaccharides, and acylating product to obtain an ester |
JPS54128482A (en) * | 1978-03-29 | 1979-10-05 | Agency Of Ind Science & Technol | Microcapsule and its preparation |
US4321117A (en) * | 1978-03-09 | 1982-03-23 | Japan Atomic Energy Research Institute | Process for preparing a polymer composition |
US4605691A (en) * | 1984-12-06 | 1986-08-12 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
US4654233A (en) * | 1984-11-21 | 1987-03-31 | Minnesota Mining And Manufacturing Company | Radiation-curable thermoplastic coating |
US4778880A (en) * | 1984-09-28 | 1988-10-18 | Symes Kenneth C | Process for producing derivatives of hydroxy compounds, the products and their uses |
US4803168A (en) * | 1983-09-01 | 1989-02-07 | Damon Biotech, Inc. | Microencapsulation with polymers |
US4806355A (en) * | 1983-06-06 | 1989-02-21 | Connaught Laboratories Limited | Microencapsulation of living tissue and cells |
US4861629A (en) * | 1987-12-23 | 1989-08-29 | Hercules Incorporated | Polyfunctional ethylenically unsaturated cellulosic polymer-based photocurable compositions |
US5128326A (en) * | 1984-12-06 | 1992-07-07 | Biomatrix, Inc. | Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3879376A (en) * | 1971-05-10 | 1975-04-22 | Oreal | Chitosan derivative, method of making the same and cosmetic composition containing the same |
US4195129A (en) * | 1975-11-26 | 1980-03-25 | Kansai Paint Co., Ltd. | Method for immobilizing enzymes and microbial cells |
JPS536483A (en) * | 1976-07-02 | 1978-01-20 | Tanabe Seiyaku Co Ltd | Composition having enzymatic activity and its preparation |
US4391909A (en) * | 1979-03-28 | 1983-07-05 | Damon Corporation | Microcapsules containing viable tissue cells |
US4393048A (en) * | 1980-02-15 | 1983-07-12 | The United States Of America As Represented By The Secretary Of The Army | Protective gel composition for wounds |
JPS5923791B2 (en) * | 1980-12-23 | 1984-06-05 | 旭化成株式会社 | Method for producing immobilized microorganisms |
US4353888A (en) * | 1980-12-23 | 1982-10-12 | Sefton Michael V | Encapsulation of live animal cells |
CA1196862A (en) * | 1983-06-01 | 1985-11-19 | Anthony M.F. Sun | Microencapsulation of living tissue and cells |
US4689293A (en) * | 1983-06-06 | 1987-08-25 | Connaught Laboratories Limited | Microencapsulation of living tissue and cells |
JPS60100516A (en) * | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | Preparation of sustained release microcapsule |
SE456346B (en) * | 1984-07-23 | 1988-09-26 | Pharmacia Ab | GEL TO PREVENT ADHESION BETWEEN BODY TISSUE AND SET FOR ITS PREPARATION |
US4851521A (en) * | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
SE459005B (en) | 1985-07-12 | 1989-05-29 | Aake Rikard Lindahl | SET TO MANUFACTURE SPHERICAL POLYMER PARTICLES |
JPS62216453A (en) * | 1986-03-17 | 1987-09-24 | Mitsubishi Electric Corp | Trunk connection system |
IT1203814B (en) * | 1986-06-30 | 1989-02-23 | Fidia Farmaceutici | ESTERS OF ALGINIC ACID |
IT1198449B (en) * | 1986-10-13 | 1988-12-21 | F I D I Farmaceutici Italiani | ESTERS OF POLYVALENT ALCOHOLS OF HYALURONIC ACID |
JPS63182302A (en) * | 1987-01-23 | 1988-07-27 | Natoko Paint Kk | Polymerizable cellulose derivative |
US5158881A (en) * | 1987-11-17 | 1992-10-27 | Brown University Research Foundation | Method and system for encapsulating cells in a tubular extrudate in separate cell compartments |
CA2015291C (en) * | 1989-04-27 | 1996-04-30 | Etsuo Hasegawa | Macromolecular endoplasmic reticulum |
EP0426368B1 (en) * | 1989-10-31 | 1995-01-04 | Howmedica Inc. | Compositions containing derivatives of chitin for preventing adhesion |
WO1991009119A1 (en) * | 1989-12-13 | 1991-06-27 | Trancel Corporation | Improved alginate microcapsules, methods of making and using same |
US5084350A (en) * | 1990-02-16 | 1992-01-28 | The Royal Institution For The Advance Of Learning (Mcgill University) | Method for encapsulating biologically active material including cells |
CA2080241A1 (en) * | 1990-04-10 | 1991-10-11 | M. Abdul Mazid | Nonthrombogenic glycosaminoglycan copolymers |
JPH0737750B2 (en) * | 1990-09-18 | 1995-04-26 | 昭和ロック株式会社 | Keyless locking device |
US5149543A (en) * | 1990-10-05 | 1992-09-22 | Massachusetts Institute Of Technology | Ionically cross-linked polymeric microcapsules |
US5529914A (en) * | 1990-10-15 | 1996-06-25 | The Board Of Regents The Univeristy Of Texas System | Gels for encapsulation of biological materials |
US5219895A (en) * | 1991-01-29 | 1993-06-15 | Autogenesis Technologies, Inc. | Collagen-based adhesives and sealants and methods of preparation and use thereof |
US5545423A (en) * | 1991-11-25 | 1996-08-13 | Vivorx, Inc. | Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials |
US5334640A (en) * | 1992-04-08 | 1994-08-02 | Clover Consolidated, Ltd. | Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods |
US5550050A (en) * | 1994-04-15 | 1996-08-27 | Cytotherapeutics, Inc. | Method for implanting encapsulated cells in a host |
-
1992
- 1992-10-29 AU AU31247/93A patent/AU3124793A/en not_active Abandoned
- 1992-10-29 EP EP92925046A patent/EP0610441A4/en not_active Withdrawn
- 1992-10-29 JP JP5508638A patent/JPH07503943A/en active Pending
- 1992-10-29 WO PCT/US1992/009364 patent/WO1993009176A2/en not_active Application Discontinuation
- 1992-10-29 CA CA002121129A patent/CA2121129A1/en not_active Abandoned
- 1992-10-29 US US08/232,054 patent/US5837747A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/472,191 patent/US5700848A/en not_active Expired - Lifetime
- 1995-06-07 US US08/482,970 patent/US5705270A/en not_active Expired - Lifetime
- 1995-06-07 US US08/475,175 patent/US5846530A/en not_active Expired - Lifetime
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3332897A (en) * | 1964-12-21 | 1967-07-25 | Nat Starch Chem Corp | Process of grafting monomers onto polysaccharides, and acylating product to obtain an ester |
US4321117A (en) * | 1978-03-09 | 1982-03-23 | Japan Atomic Energy Research Institute | Process for preparing a polymer composition |
JPS54128482A (en) * | 1978-03-29 | 1979-10-05 | Agency Of Ind Science & Technol | Microcapsule and its preparation |
US4806355A (en) * | 1983-06-06 | 1989-02-21 | Connaught Laboratories Limited | Microencapsulation of living tissue and cells |
US4803168A (en) * | 1983-09-01 | 1989-02-07 | Damon Biotech, Inc. | Microencapsulation with polymers |
US4778880A (en) * | 1984-09-28 | 1988-10-18 | Symes Kenneth C | Process for producing derivatives of hydroxy compounds, the products and their uses |
US4654233A (en) * | 1984-11-21 | 1987-03-31 | Minnesota Mining And Manufacturing Company | Radiation-curable thermoplastic coating |
US4605691A (en) * | 1984-12-06 | 1986-08-12 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
US5128326A (en) * | 1984-12-06 | 1992-07-07 | Biomatrix, Inc. | Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same |
US4861629A (en) * | 1987-12-23 | 1989-08-29 | Hercules Incorporated | Polyfunctional ethylenically unsaturated cellulosic polymer-based photocurable compositions |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8834451B2 (en) | 2002-10-28 | 2014-09-16 | Smith & Nephew Plc | In-situ wound cleansing apparatus |
US9205001B2 (en) | 2002-10-28 | 2015-12-08 | Smith & Nephew Plc | Apparatus for aspirating, irrigating and cleansing wounds |
US9387126B2 (en) | 2002-10-28 | 2016-07-12 | Smith & Nephew Plc | Apparatus for aspirating, irrigating and cleansing wounds |
US9139664B2 (en) | 2007-02-19 | 2015-09-22 | Marine Polymer Technologies, Inc. | Hemostatic compositions and therapeutic regimens |
US9139663B2 (en) | 2007-02-19 | 2015-09-22 | Marine Polymer Technologies, Inc. | Hemostatic compositions and therapeutic regimens |
US8858964B2 (en) | 2010-04-15 | 2014-10-14 | Marine Polymer Technologies, Inc. | Anti-bacterial applications of poly-N-acetylglucosamine nanofibers |
US9198928B2 (en) | 2010-04-15 | 2015-12-01 | Marine Polymer Technologies, Inc. | Anti-bacterial applications of poly-N-acetylglucosamine nanofibers |
US8998866B2 (en) | 2010-07-02 | 2015-04-07 | Smith & Nephew Plc | Provision of wound filler |
Also Published As
Publication number | Publication date |
---|---|
JPH07503943A (en) | 1995-04-27 |
AU3124793A (en) | 1993-06-07 |
CA2121129A1 (en) | 1993-05-13 |
US5700848A (en) | 1997-12-23 |
US5837747A (en) | 1998-11-17 |
EP0610441A4 (en) | 1996-01-10 |
EP0610441A1 (en) | 1994-08-17 |
US5846530A (en) | 1998-12-08 |
WO1993009176A2 (en) | 1993-05-13 |
US5705270A (en) | 1998-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1993009176A3 (en) | Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release | |
AU5217286A (en) | Process for making polymer particles, polymer particles and their use | |
Sawhney et al. | Modification of islet of langerhans surfaces with immunoprotective poly (ethylene glycol) coatings via interfacial photopolymerization | |
US5705191A (en) | Sustained delivery of active compounds from tubules, with rational control | |
BR9306041A (en) | Geis for the encapsulation of biological materials | |
GB1148574A (en) | Molecular sieve coated particulate adsorbent and processes using same | |
GB2243778A (en) | Adhesive drug delivery composition | |
AU5795896A (en) | Controlling the porosity and permeation of a web | |
NO933842L (en) | Implantable, biocompatible, immunoisolatory carrier for indication of selected therapeutic products | |
MY123675A (en) | Process for conditioning substances. | |
ES2152409T3 (en) | MULTIPLE ENCAPSULATE OF OLEOPHILIC SUBSTANCES. | |
EP0141374A3 (en) | Capsule production using biologically active substrates | |
AU8209787A (en) | Adhesive products | |
FR2272638B1 (en) | ||
FI893959A0 (en) | Process for the preparation of particles containing a biologically produced material in a polymer matrix | |
KR850005271A (en) | Method for preparing oral medicament consisting of polycaprolactone matrix | |
ITMI20082284A1 (en) | COMPOSITE MATERIAL EQUIPPED WITH PROPERTIES OF SELF-REPARATION AND RELEASE OF ACTIVE PRINCIPLES, FOR BIOMEDICAL APPLICATIONS | |
DE69809746D1 (en) | MODIFYING GLYCOSIDES, COMPOSITIONS CONTAINING MODIFIED GLYCOSIDES AND METHOD FOR THE PRODUCTION THEREOF | |
AR008769A1 (en) | METHOD FOR THE DISTRIBUTION OF ZEOLITE POWDER, SUCH AS MOLECULAR SCREENING POWDER AND FOR THE MANUFACTURE OF AN ABSORBENT ARTICLE CONTAINING THE DISTRIBUTED ZEOLITE POWDER | |
AU2117588A (en) | Process for microencapsulation, uses of polymers prepared by said process, and compositions containing polymers prepared by said process | |
Zhang et al. | In situ preparation and properties of poly (vinyl alcohol)/carboxymethyl chitosan/cyanidin hydrogel films | |
BR9508240A (en) | Polymeric film and its production process | |
JPS54119585A (en) | Production of polymer composition containing physiologically active substance | |
CA2445363A1 (en) | Semi-permeable microcapsule with covalently linked layers and method for producing same | |
WO1987004367A1 (en) | Covalent membranes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AT AU BB BG BR CA CH CS DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO PL RO RU SD SE US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE BF BJ CF CG CI CM GA GN ML MR SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AT AU BB BG BR CA CH CS DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO PL RO RU SD SE US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE BF BJ CF CG CI CM GA GN ML MR SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2121129 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08232054 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1992925046 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1992925046 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 1995 475175 Country of ref document: US Date of ref document: 19950607 Kind code of ref document: A Ref document number: 1995 472191 Country of ref document: US Date of ref document: 19950607 Kind code of ref document: A |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1992925046 Country of ref document: EP |